Literature DB >> 12419567

Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy.

Andrew J Burger1, John A D'Elia, Larry A Weinrauch, Israel Lerman, Abhishek Gaur.   

Abstract

BACKGROUND: Cardiac autonomic neuropathy is a common complication of long-standing, type 1 diabetes and is associated with increased morbidity and mortality. Impaired heart rate variability is a sensitive and reproducible marker of cardiac autonomic neuropathy. We sought to examine the relationship between cardiac autonomic neuropathy as assessed by heart rate variability and overt nephropathy, with emphasis on the progression of renal dysfunction over 1 year.
METHOD: Baseline and 12 month clinical and biochemical characteristics, as well as autonomic function tests, were analyzed in 23, type 1 diabetic patients (mean age 37+/-10 years, 65% males), who were prospectively enrolled as a part of a multi-center investigation. In addition, ambulatory, 24-h, 3-channel electrocardiograms were recorded, and heart rate variability indices were assessed in the time and frequency domains over the same period.
RESULTS: All heart rate variability indices were markedly decreased in our study population. On univariate analysis, heart rate variability was associated with creatinine clearance, and to a lesser extent, mean 24-h blood pressures and cholesterol. On multivariate analysis, only heart rate variability was a significant and independent predictor of abnormalities in creatinine clearance. Severe reduction in heart rate variability at baseline was also significantly associated with the further deterioration in renal function at 1 year.
CONCLUSION: Heart rate variability is significantly reduced in long-standing, type 1 diabetics with proteinuria or overt nephropathy. Marked abnormalities in heart rate variability are significantly associated with and predictive of progressive renal deterioration at 1 year. These findings may have implications for aggressive medical intervention to improve prognosis and survival in this population.

Entities:  

Mesh:

Year:  2002        PMID: 12419567     DOI: 10.1016/s0167-5273(02)00346-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

Review 1.  Improvements in heart rate variability with exercise therapy.

Authors:  Faye S Routledge; Tavis S Campbell; Judith A McFetridge-Durdle; Simon L Bacon
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

2.  Baroreflex analysis in diabetes mellitus: linear and nonlinear approaches.

Authors:  Michal Javorka; Zuzana Lazarova; Ingrid Tonhajzerova; Zuzana Turianikova; Natasa Honzikova; Bohumil Fiser; Kamil Javorka; Mathias Baumert
Journal:  Med Biol Eng Comput       Date:  2010-11-19       Impact factor: 2.602

3.  Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study.

Authors:  Paul E Drawz; Denise C Babineau; Carolyn Brecklin; Jiang He; Radhakrishna R Kallem; Elsayed Z Soliman; Dawei Xie; Dina Appleby; Amanda H Anderson; Mahboob Rahman
Journal:  Am J Nephrol       Date:  2013-12-14       Impact factor: 3.754

4.  Predictors of heart rate variability and its prognostic significance in chronic kidney disease.

Authors:  Preeti Chandra; Robin L Sands; Brenda W Gillespie; Nathan W Levin; Peter Kotanko; Margaret Kiser; Fredric Finkelstein; Alan Hinderliter; Rodica Pop-Busui; Sanjay Rajagopalan; Rajiv Saran
Journal:  Nephrol Dial Transplant       Date:  2011-09-12       Impact factor: 5.992

Review 5.  Heart rate and blood pressure: any possible implications for management of hypertension?

Authors:  Scott Reule; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

6.  Heart rate variability predicts ESRD and CKD-related hospitalization.

Authors:  Daniel J Brotman; Lori D Bash; Rehan Qayyum; Deidra Crews; Eric A Whitsel; Brad C Astor; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

7.  Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat.

Authors:  Megan S Johnson; Vincent G DeMarco; Cheryl M Heesch; Adam T Whaley-Connell; Rebecca I Schneider; Nathan T Rehmer; Roger D Tilmon; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-05       Impact factor: 4.733

8.  Oxidative stress is associated with decreased heart rate variability in patients with chronic kidney disease.

Authors:  Shannon B Fadaee; Kassia S Beetham; Erin J Howden; Tony Stanton; Nicole M Isbel; Jeff S Coombes
Journal:  Redox Rep       Date:  2016-04-19       Impact factor: 4.412

9.  Left ventricular mass reduction in type 1 diabetic patients with nephropathy.

Authors:  Larry A Weinrauch; Andrew Burger; Ray E Gleason; Annette T Lee; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

10.  Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus.

Authors:  Yong Kyun Kim; Jung Eun Lee; Yoon Goo Kim; Dae Joong Kim; Ha-Young Oh; Chul Woo Yang; Kwang-Won Kim; Wooseong Huh
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.